SCHEMBL23691126

SCHEMBL23691126

CC(C)/N=N\c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.55
▸ CYP1A2 P05177 2/20 0.48
▸ TDP1 Q9NUW8 3/20 0.43
▸ MAPK1 P28482 3/20 0.43
▸ TSHR P16473 2/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ MAPT P10636 5/20 0.42
▸ KMT2A Q03164 4/20 0.42
▸ MEN1 O00255 3/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ PKM P14618 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ CYP1A1 P04798 1/20 0.39
▸ CYP1B1 Q16678 1/20 0.39
▸ TRPA1 O75762 2/20 0.38
▸ NOS3 P29474 2/20 0.37
▸ NOS1 P29475 2/20 0.37
▸ MAOA P21397 1/20 0.37
▸ MAOB P27338 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12677158 1.00 ALDH1A1 (0.55) ALDH1A1CYP1A2TDP1MAPK1TSHR
SCHEMBL10153008 1.00 ALDH1A1 (0.55) ALDH1A1CYP1A2TDP1MAPK1TSHR
SCHEMBL13074567 0.77 NPC1 (0.43) ALDH1A1TDP1MAPK1MAPTKMT2A
SCHEMBL28553516 0.77 CYP1A2 (0.50) ALDH1A1CYP1A2TDP1MAPK1TSHR
SCHEMBL10030527 0.75 CYP2C9 (0.44) ALDH1A1TDP1MAPK1MAPTKMT2A
SCHEMBL10438311 0.74 ALDH1A1 (0.55) ALDH1A1CYP1A2TDP1MAPK1TSHR
SCHEMBL180555 0.74 ALDH1A1 (0.55) ALDH1A1CYP1A2TDP1MAPK1TSHR
Azobenzene SCHEMBL11328902 0.74 ALDH1A1 (0.86) ALDH1A1TDP1MAPK1TSHRHSD17B10
Azobenzene SCHEMBL11328908 0.74 ALDH1A1 (0.86) ALDH1A1TDP1MAPK1TSHRHSD17B10
SCHEMBL10152992 0.73 TRPA1 (0.59) ALDH1A1TDP1MAPK1TSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12030876-B2 Aryl hydrocarbon receptor (AHR) agonists and uses thereof Ikena Oncology, Inc. (US) 2024-07-09 — — US disclosed
US-12030876-B2 Aryl hydrocarbon receptor (AHR) agonists and uses thereof Ikena Oncology, Inc. (US) 2024-07-09 — — US disclosed
US-20230295147-A1 ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF ARYL THERAPEUTICS, INC. 2023-09-21 — — US disclosed
US-20230295147-A1 ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF ARYL THERAPEUTICS, INC. 2023-09-21 — — US disclosed
US-20210230153-A1 ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF ARYL THERAPEUTICS, INC. 2021-07-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12030876-B2 Aryl hydrocarbon receptor (AHR) agonists and uses thereof AHR, ARNT, HCAR1 ALDH1A1 289/4885CYP1A2 26/4885TDP1 3915/4885
US-20230295147-A1 ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF AHR, ARNT, HCAR1 ALDH1A1 289/4885CYP1A2 26/4885TDP1 3915/4885
US-20210230153-A1 ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF AHR, ARNT, HCAR1 ALDH1A1 289/4885CYP1A2 26/4885TDP1 3915/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback